Literature DB >> 8579267

Bilateral gluteus maximus V-Y advancement musculocutaneous flaps for the coverage of large sacral pressure sores: revisit and refinement.

T H Chen1.   

Abstract

Surgical management of the sacral defect using the gluteal muscle or musculocutaneous flap has been well accepted over the years. In this study, refinements in the bilateral gluteus maximus V-Y advancement musculocutaneous flaps were made. These refinements include having sharper angle (60 degrees or less) at the donor sites of the flap, cutting the edges of the gluteal muscle of 3 cm beyond the skin flap, and cutting most parts of the gluteal muscle at a depth of only 2.5 cm (at the level of upper third portion). These improvements result in less tension closure of the donor site, easier closure of the advanced flaps in two planes without tension, and better preservation of most parts of the gluteal muscular insertions to the femur and their functions. The design of V-Y advancement has successfully maintained the superior and inferior gluteal vessels and inferior gluteal nerve. In this study, the average sacral defect was more than 12 cm in diameter, and each advanced flap was 15 x 12 x 3 cm in size. Of the 63 consecutive patients undergoing bilateral gluteus maximus V-Y advancement musculocutaneous flaps with refinements for coverage of large sacral pressure sores, 59 (93%) achieved complete healing after an average follow-up period of 28 months. Only 4 patients had recurrences of sacral sore. In this study, the duration of hospital stay for flap coverage averaged 38.5 days. Four patients (6%) had superficial dehiscences of the donor site requiring skin grafting. Ten patients (16%) developed stitch abscesses and 9 patients (14%) had wound infections, but no flap was lost. No significant functional impairment related to the flap procedure was noted. The operative technique described in this paper is not only simple and noninvasive, but with our refinements of flap design, the bilateral gluteus maximus V-Y advancement musculocutaneous flaps also provide reliable and durable coverage for large sacral pressure sores.

Entities:  

Mesh:

Year:  1995        PMID: 8579267     DOI: 10.1097/00000637-199511000-00008

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  6 in total

1.  Improvisations in classic and modified techniques of flap surgery to improve the success rate for pressure ulcer healing in patients with spinal cord injury.

Authors:  Roop Singh; Raghubir Singh; Rajesh K Rohilla; Narender K Magu; Rakesh Goel; Kiranpreet Kaur
Journal:  Int Wound J       Date:  2012-06-14       Impact factor: 3.315

2.  Pedicled fasciocutaneous flap of multi-island design for large sacral defects.

Authors:  Yunqin Xu; Henglin Hai; Zaiyue Liang; Shuiyun Feng; Caoyang Wang
Journal:  Clin Orthop Relat Res       Date:  2008-12-02       Impact factor: 4.176

3.  The pedicled myocutaneous flap as a choice reconstructive technique for immediate adjuvant brachytherapy in sarcoma treatment.

Authors:  S C Saba; A Shaterian; C Tokin; M K Dobke; A M Wallace
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

4.  Simple and Efficient Pressure Ulcer Reconstruction via Primary Closure Combined with Closed-Incision Negative Pressure Wound Therapy (CiNPWT)-Experience of a Single Surgeon.

Authors:  Kuo-Feng Hsu; Li-Ting Kao; Pei-Yi Chu; Chun-Yu Chen; Yu-Yu Chou; Dun-Wei Huang; Ting-Hsuan Liu; Sheng-Lin Tsai; Chien-Wei Wu; Chih-Chun Hou; Chih-Hsin Wang; Niann-Tzyy Dai; Shyi-Gen Chen; Yuan-Sheng Tzeng
Journal:  J Pers Med       Date:  2022-01-29

5.  The unresolved case of sacral chordoma: from misdiagnosis to challenging surgery and medical therapy resistance.

Authors:  Fabio Garofalo; Dimitrios Christoforidis; Pietro G di Summa; Béatrice Gay; Stéphane Cherix; Wassim Raffoul; Nicolas Demartines; Maurice Matter
Journal:  Ann Coloproctol       Date:  2014-06-23

6.  Versatility of V-Y Flap in Gluteal Area.

Authors:  Ahmed El-Sabbagh
Journal:  World J Plast Surg       Date:  2016-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.